Xcelerate Announces Notice of Allowance for U.S. Patent Application No. 18/187,352, titled “Surgical Tool with Targeting”

MAULDIN, SC / September 16, 2026 / Xcelerate Inc. (OTC: XCRT) today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 18/187,352, titled “Surgical Tool with Targeting Guidance.”

The Notice of Allowance represents an important milestone in the continued development of Xcelerate’s intellectual property portfolio and follows the Company’s previously announced progress on its intellectual property/patent portfolio.

In addition to the U.S. application, international patent protection for the technology in Europe and China remains pending.

“I would like to thank Dr. Anja Glisovic for her years of research and development, without which Xcelerate would never have been able to achieve this important step toward our goal of Transforming Breakthrough Engineering into Scalable Medical Solutions. I would also like to thank Dr. Dilan Ellegala for his continued support and clinical input,” said Mike O’Shea, CEO of Xcelerate.

“Xcelerate’s model is to bridge breakthrough engineering and clinical care by advancing protected technologies toward practical MedTech applications. This patent is aligned with that strategy: an engineering-led optical and sensing architecture designed for integration into real surgical products.”

A Technology Platform with Broad Potential Applications

This patent represents a technology platform rather than a single surgical-tool configuration, with potential applicability across a broad range of environments, including:

• Minimally invasive and difficult-to-access surgical procedures.
• Orthopedic, dental, and other powered-instrument applications.
• Navigation-enabled and robot-assisted surgical platforms.
• Procedures in which a first-person working view, target indication, or measured approach distance could complement existing imaging.
• Integration with established image-guided workflows rather than replacement of external imaging.

The architecture may be particularly suited to established surgical-tool, navigation, and robotic-surgery companies seeking to add differentiated sensing and guidance capabilities to existing powered-instrument families.

Xcelerate has begun the process of identifying potential strategic partners that may assist in transitioning the technology toward practical use.

“This milestone further strengthens our intellectual property portfolio and supports our strategy of identifying opportunities where protected engineering technologies can be developed into practical healthcare applications,” added O’Shea.

ABOUT XCELERATE INC.

In May 2020, Xcelerate commenced implementation of a new business plan that encompasses two separate but related businesses within the medical industry, including (i) owning and licensing the rights to various forms of medical equipment and portfolio of patents, patents pending and technology licenses and (ii) development of virtual health technology to assist patients in developing countries obtain medical care by extending the reach of physicians through the use of that technology.

For more information

visit www.xcelerate.global or contact us at 854-900-2020 or email info@xcelerate.global.

Join our investor community newsletter: ir@xclerate.global

Connect with us:
Website | X | Youtube | Instagram | Tiktok 

SAFE HARBOR

This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend,” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and actual results may differ materially from those projected in forward-looking statements resulting from various factors.